Does neoadjuvant/perioperative chemotherapy improve overall survival for T2N0 gastric adenocarcinoma?-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Does neoadjuvant/perioperative chemotherapy improve overall survival for T2N0 gastric adenocarcinoma?

Published:2017-11-11 Issue:4 Volume:117 Page:659-670
ISSN:0022-4790
Container-title:Journal of Surgical Oncology
language:en
Short-container-title:J Surg Oncol

Author:

Gabriel Emmanuel¹^ORCID,Attwood Kristopher²,Narayanan Sumana³,Brady Maureen³,Nurkin Steven³,Hochwald Steven³,Kukar Moshim³

Affiliation:

1. Department of Surgery; Section of Surgical Oncology; Mayo Clinic; Jacksonville Florida

2. Department of Biostatistics; Roswell Park Cancer Institute Buffalo; Buffalo New York

3. Department of Surgical Oncology; Roswell Park Cancer Institute Buffalo; Buffalo New York

Funder

National Cancer Institute

Publisher

Wiley

Subject

Oncology,General Medicine,Surgery

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jso.24894/fullpdf

Reference29 articles.

1. http://www.nccn.org/professionals/physician_gls/pdf/

2. Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer;Cunningham;N Engl J Med,2006

3. Perioperative chemotherapy compared with surgery alone for resectable gastroesophageal adenocarcinoma: an FNCLCC and FFCD multicenter phase III trial;Ychou;J Clin Oncol,2011

4. Preoperative chemoradiotherapy for esophageal or junctional cancer;van Hagen;N Engl J Med,2012

5. Management of locally advanced adenocarcinoma of the esophagus and gastroesophageal junction: finally a consensus;Kleinberg;Curr Treat Options Oncol,2015

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. ASO Author Reflections: Neoadjuvant Chemotherapy in cT2N0M0 Gastric Cancer; Time to Revisit Current Recommendations?;Annals of Surgical Oncology;2024-07-04

2. Accuracy of clinical staging for intramural (T2) gastric cancer: Survival outcomes following upfront surgical resection compared to risk of overtreatment with neoadjuvant therapy;Surgical Oncology Insight;2024-06

3. Neoadjuvant Chemotherapy Does Not Improve Survival in cT2N0M0 Gastric Adenocarcinoma Patients: A Multicenter Propensity Score Analysis;Annals of Surgical Oncology;2024-05-18

4. Changes in Oncological Surgical Principles Driven by Advances in Preoperative Treatments;Therapeutics and Clinical Risk Management;2023-08

5. A new scoring system to evaluate adjuvant chemotherapy for patients with T2N0M0 gastric cancer after D2 gastrectomy;World Journal of Gastroenterology;2022-10-14

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3